24-norursodeoxycholic acid has been researched along with etiocholanolone in 1 studies
| Studies (24-norursodeoxycholic acid) | Trials (24-norursodeoxycholic acid) | Recent Studies (post-2010) (24-norursodeoxycholic acid) | Studies (etiocholanolone) | Trials (etiocholanolone) | Recent Studies (post-2010) (etiocholanolone) |
|---|---|---|---|---|---|
| 35 | 2 | 27 | 1,139 | 26 | 66 |
| Protein | Taxonomy | 24-norursodeoxycholic acid (IC50) | etiocholanolone (IC50) |
|---|---|---|---|
| Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | Mus musculus (house mouse) | 0.021 | |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.293 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auwerx, J; Gioiello, A; Hofmann, AF; Macchiarulo, A; Pellicciari, R; Saladin, R; Sato, H; Schoonjans, K; Thomas, C; Une, M | 1 |
1 other study(ies) available for 24-norursodeoxycholic acid and etiocholanolone
| Article | Year |
|---|---|
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Topics: Animals; Bile Acids and Salts; CHO Cells; Cricetinae; Cricetulus; Drug Design; Drug Evaluation, Preclinical; Hormones; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptors, G-Protein-Coupled; Stereoisomerism; Structure-Activity Relationship | 2008 |